Neonatal hypoxic-ischemic (HI) brain injury results in devastating, life-long disability for the affected children. At present, hypothermia is the only treatment for neonatal HI and it is incompletely effective. 45% of treated infants still die or sustain severe neurodevelopmental disability following HI. Designing safe, effective, mechanistically novel adjuvant therapies is the highest priority in this field of research. In concert, there is a need to develop mechanistically-based, reliable biomarkers to track novel therapies and measure their efficacy. Our identification of programmed necrosis as a mechanism of injury in neonatal HI provides an opportunity to identify novel therapies. That programmed necrosis may be operative in neonatal HI is clinically compelling. Programmed necrosis, unlike classical necrosis, is regulated, treatable, and is well understood in vitro. How and whether hypothermia acts to inhibit programmed necrosis is unknown and very important to the successful development of adjuvant therapies for neonatal HI. The in vivo neural target of hypothermia and programmed necrosis inhibitors is also a gap in our knowledge. Effects of hypothermia on neurons are best known. Little is known about the effects of hypothermia on glia and nothing is known about the effects of programmed necrosis inhibitors. Glia, oligodendroglia and astrocytes, clearly contribute to the overall """"""""encephalopathy"""""""" resulting from neonatal HI. Astrocytes, in particular, may play a pivotal role in initiation of and protection from HI by both hypothermia and programmed necrosis inhibitors. Because of their possible involvement in the initiation and response to HI injury and treatment, astrocytic release of glial fibrillary acid proein (GFAP) may be the reliable, regionally specific, mechanistically-based biomarker that we seek for neonatal HI brain injury. In this proposal, we will use an established model of neonatal HI and hypothermia address each of these research priorities and areas of knowledge gap. We will test the hypothesis that hypothermia provides neuroprotection following neonatal HI by interrupting programmed necrosis. Subsequently, using data from these experiments we will test combinations of hypothermia, anti-programmed necrosis and anti-apoptosis treatments for treatment of neonatal HI and GFAP as an experimental biomarker. In doing so we will forge new pathways in neonatal brain injury research These experiments address critical, timely, and highly relevant issues in neonatal brain injury.

Public Health Relevance

These studies address one of the highest priorities in neonatal brain injury;finding novel therapies to combine with our current treatment for neonatal hypoxic ischemic brain injury. Additionally, we will be applying a promising clinical biomarker to an experimental model, to test its ability to predict severity of injury and response to treatment. Results from these studies have the potential to fundamentally alter our understanding of how hypoxic ischemic injury causes brain damage and how to significantly improve treatment for this devastating injury.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD070996-03
Application #
8660703
Study Section
Developmental Brain Disorders Study Section (DBD)
Program Officer
Urv, Tiina K
Project Start
2012-08-17
Project End
2017-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
3
Fiscal Year
2014
Total Cost
$328,492
Indirect Cost
$125,719
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Tatarinova, Tatiana V; Lysnyansky, Inna; Nikolsky, Yuri V et al. (2016) The mysterious orphans of Mycoplasmataceae. Biol Direct 11:2
Lemmon, Monica E; Donohue, Pamela K; Parkinson, Charlamaine et al. (2016) Parent Experience of Neonatal Encephalopathy: The Need for Family-Centered Outcomes. J Child Neurol :
Gerner, G J; Burton, V J; Poretti, A et al. (2016) Transfontanellar duplex brain ultrasonography resistive indices as a prognostic tool in neonatal hypoxic-ischemic encephalopathy before and after treatment with therapeutic hypothermia. J Perinatol 36:202-6
Chavez-Valdez, Raul; Flock, Debbie L; Martin, Lee J et al. (2016) Endoplasmic reticulum pathology and stress response in neurons precede programmed necrosis after neonatal hypoxia-ischemia. Int J Dev Neurosci 48:58-70
Xu, Jiadi; Qin, Qin; Wu, Dan et al. (2016) Steady pulsed imaging and labeling scheme for noninvasive perfusion imaging. Magn Reson Med 75:238-48
Flegontov, Pavel; Changmai, Piya; Zidkova, Anastassiya et al. (2016) Genomic study of the Ket: a Paleo-Eskimo-related ethnic group with significant ancient North Eurasian ancestry. Sci Rep 6:20768
Johnson, C T; Burd, I; Raghunathan, R et al. (2016) Perinatal inflammation/infection and its association with correction of metabolic acidosis in hypoxic-ischemic encephalopathy. J Perinatol 36:448-52
Lee, Jennifer K; Poretti, Andrea; Perin, Jamie et al. (2016) Optimizing Cerebral Autoregulation May Decrease Neonatal Regional Hypoxic-Ischemic Brain Injury. Dev Neurosci :
Tsimis, Michael E; Johnson, Clark T; Raghunathan, Radhika S et al. (2016) Risk factors for periventricular white matter injury in very low birthweight neonates. Am J Obstet Gynecol 214:380.e1-6
Klein, Jessica L; Lemmon, Monica E; Northington, Frances J et al. (2016) Clinical and neuroimaging features as diagnostic guides in neonatal neurology diseases with cerebellar involvement. Cerebellum Ataxias 3:1

Showing the most recent 10 out of 46 publications